Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of the ITEMS (Immunomodulatory Treatment of Early-onset MS) study group

被引：0
|
作者：
Ghezzi, A
Amato, MP
Gallo, P
Marrosu, MG
Martinelli, V
Milani, N
Milanese, C
Moiola, L
Patti, F
Pozzilli, C
Trojano, M
Zaffaroni, M
Pilato, V
Comi, G
机构：
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S234 / S234
页数：1
相关论文
共 50 条
  • [1] Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study
    Ghezzi, A
    Amato, MP
    Capobianco, M
    Gallo, P
    Marrosu, G
    Martinelli, V
    Milani, N
    Milanese, C
    Moiola, L
    Patti, F
    Pilato, V
    Pozzilli, C
    Trojano, M
    Zaffaroni, M
    Comi, G
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (04) : 420 - 424
  • [2] Disease modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian Co-operative Study
    Ghezzi, A
    Amato, MP
    Gallo, R
    Marrosu, G
    Martinelli, V
    Milani, N
    Milanese, C
    Moiola, L
    Patti, F
    Pilato, V
    Pozzilli, C
    Trojano, M
    Zaffaroni, M
    Comi, G
    JOURNAL OF NEUROLOGY, 2004, 251 : 147 - 147
  • [3] Tolerability and efficacy of disease-modifying therapies in childhood and juvenile multiple sclerosis
    Tenembaum, SN
    Segura, MJ
    Fejerman, N
    NEUROLOGY, 2001, 56 (08) : A361 - A361
  • [4] Use of disease-modifying drugs in multiple sclerosis: A population based study
    Noyes, K.
    Bajorska, A.
    Schwid, S.
    Holloway, R.
    Dick, A.
    VALUE IN HEALTH, 2008, 11 (03) : A150 - A151
  • [5] Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study
    Wijnands, Jose Maria Andreas
    Zhu, Feng
    Kingwell, Elaine
    Fisk, John David
    Evans, Charity
    Marrie, Ruth Ann
    Zhao, Yinshan
    Tremlett, Helen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10): : 1050 - 1056
  • [6] Pregnancy exposure to disease-modifying drugs in multiple sclerosis: a prospective study
    Pablo Cuello, Juan
    Salgado Camara, Paula
    Garcia Dominguez, Jose Manuel
    Lozano Ros, Alberto
    Mas Serrano, Miguel
    Martinez Gines, Maria Luisa
    MEDICINA CLINICA, 2020, 154 (06): : 214 - 217
  • [7] Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)
    Stamatellos, Vasileios-Periklis
    Papazisis, Georgios
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2023, 18 (01) : 39 - 50
  • [8] Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
    Spessotto, Caroline
    Cavalli, Hanaie
    Eboni, Audred
    Machado, Rafael
    Mousquer, Analara
    Palazzo, Lara
    Finkelsztejn, Alessandro
    Goncalves, Marcos
    Sato, Henry
    Siquineli, Fabio
    Fragoso, Yara
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 141 - 141
  • [9] Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
    Spessotto, Caroline Vieira
    Cavalli, Hanaie
    Biondo Eboni, Audred Cristina
    Machado, Rafael Berlezi
    Mousquer, Analara Munardi
    Palazzo, Lara Both
    Finkelsztejn, Alessandro
    Magno Goncalves, Marcus Vinicius
    Sato, Henry Koiti
    Siquineli, Fable
    Fragoso, Yara Dadalti
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (08) : 617 - 620
  • [10] Suboptimal Treatment Outcomes In Employees With Multiple Sclerosis Initiating Disease-modifying Drugs
    Hersh, C. M.
    Brook, R. A.
    Rohrbacker, N. J.
    Beren, I. A.
    Lebson, L.
    Henke, C.
    Phillips, A. L.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 35 - 35
12345